Document Detail


Laboratory medicine: the precursors strike back.
MedLine Citation:
PMID:  21837931     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Laboratory Medicine represents a major component of healthcare and nowadays it is involved in more than seventy percent of medical decisions. The value of any innovative laboratory test will depend on its clinical sensitivity and specificity. This clinical value is of course influenced by the analytical performance and reliability of the assay. Some spectacular advances in the understanding of circulating forms were recently accomplished with an emphasis place on prohormones and analytes precursors. Release of prohormones in the blood flow may be of major impact to improve diagnosis and risk stratification but may also influence the analytical specificity of some commercial assays. The goal of this short review is to discuss some perspectives related to some analytes' precursors that have recently been evidenced to affect assay specificity or increase assay discriminatory power.
Authors:
D Gruson; C Lindberg
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta clinica Belgica     Volume:  66     ISSN:  0001-5512     ISO Abbreviation:  Acta Clin Belg     Publication Date:    2011 May-Jun
Date Detail:
Created Date:  2011-08-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370306     Medline TA:  Acta Clin Belg     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  216-20     Citation Subset:  IM    
Affiliation:
Department of Laboratory Medicine, Cliniques Universitaires St-Luc, Brussels, Belgium. damien.gruson@uclouvain.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Personality traits in chronic pain patients are associated with low acceptance and catastrophizing a...
Next Document:  Thoracic duct ligation as treatment of chylothorax due to vena cava superior thrombosis.